Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1197005018 | Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/15mg/1mL liquid (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1210318012 | Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/15mg/1mL liquid | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2830731000052118 | karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Is a | Product containing dextromethorphan (medicinal product) | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Is a | Product containing pseudoephedrine (medicinal product) | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Is a | Product containing carbinoxamine (medicinal product) | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Is a | dextrometorfanhydrobromid | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Has active ingredient | Ethanolamine | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Has active ingredient | Carbinoxamine (substance) | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Has active ingredient | Pseudoephedrine (substance) | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Has active ingredient | Dextromethorphan hydrobromide (substance) | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Is a | karbinoxaminmaleat + dextrometorfanhydrobromid + pseudoefedrinhydroklorid | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Has active ingredient | Pseudoephedrine hydrochloride | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Has active ingredient | Carbinoxamine maleate | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Has manufactured dose form | oral vätska | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Has active ingredient | Cardiovascular agent (substance) | false | Inferred relationship | Some | ||
| karbinoxaminmaleat 2 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, vätska | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR